Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Folincyr-S is a marketed oral nutritional supplement developed by El Dorado Bio Tech. It is a fixed-dose combination of three active B-vitamins: L-methylfolate (the active form of vitamin B9), mecobalamin (the active form of vitamin B12), and pyridoxal 5-phosphate (the active form of vitamin B6). This combination is designed to support nerve health, promote red blood cell production, and regulate homocysteine levels. It is primarily indicated for managing nutritional deficiencies, neuropathy, anemia, and general weakness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on L-methylfolate + mecobalamin + pyridoxal 5-phosphate.